Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.
about
Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophreniaA review of MRI findings in schizophreniaMetabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studiesNeurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysisProton magnetic resonance spectroscopy of the human brain in schizophrenia.Magnetic resonance spectroscopy and schizophrenia: what have we learnt?T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.Understanding predisposition to schizophrenia: toward intervention and prevention.Pathogenesis of schizophrenia: Part I. Symptomatology, cognitive characteristics and brain morphology.Approaches for adolescents with an affected family member with schizophrenia.Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: a critical review of the methodology.MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders.Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis.Deconstructing psychosis with human brain imaging.Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy.Imaging genetics of structural brain connectivity and neural integrity markers.Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study.Biological phenotypes and genetic research on schizophreniaNeural models of schizophreniaSchizophrenia: vulnerability versus disease.Intermediate phenotypes in schizophrenia: a selective review.Prefrontal deviations in function but not volume are putative endophenotypes for schizophreniaMagnetic resonance spectroscopy of limbic structures displays metabolite differences in young unaffected relatives of schizophrenia probands.Imaging genomics and response to treatment with antipsychotics in schizophrenia.Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblingsImpact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 TeslaN-Acetyl-Aspartate Level is Decreased in the Prefrontal Cortex in Subjects At-Risk for Schizophrenia.Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability.Magnetoencephalographic gamma power reduction in patients with schizophrenia during resting condition.Early and broadly defined psychosis risk mental statesProton magnetic resonance spectroscopy of the frontal, cingulate and perirolandic cortices and its relationship to skin conductance in patients with schizophrenia.Proton MRS in twin pairs discordant for schizophrenia.Evidence that hippocampal-parahippocampal dysfunction is related to genetic risk for schizophrenia.Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
P2860
Q24562939-DDE03A5A-D089-4C04-94B4-DCD9F0327498Q24657354-5695B4C0-8DE5-46E8-AB49-62A6E8FB03DDQ26865740-07E3D263-2AC8-404A-B743-B92720D51703Q30565982-1FD18335-6F64-4FCC-915A-46FDE12C81F5Q30587234-55BCBCC4-C0D3-4E60-8DC1-816D8241F337Q30629018-3B29F593-0461-4868-9CEA-F4762C770796Q30648464-D0C333F3-95C4-4091-BA43-12470AB35696Q30719343-E44DA8E7-1D8D-4042-8D36-0C3BFEBC5A34Q30760640-87BE25E1-7A4C-4649-9737-9C750DEB8C33Q30945269-D776D784-14C4-4DFD-9DEA-F44ADDAE6725Q30949960-AC18DA90-7581-4FDB-AD9A-C11DEFEBAE5BQ30957247-1110BF8A-2F47-4B78-9909-789821C48365Q31001850-9D4D020E-E3EA-48D5-8728-46862DE2D582Q31114592-69C20B86-4466-480A-BD68-1FAA1FAB8D16Q33186072-9464B0E7-D4EF-4844-9246-691627265805Q33516442-0EA843C5-B37E-42D9-A02A-D5077909C67AQ34482007-D43E5EE6-6297-44C4-BDAF-E62C43A31512Q34721909-AD40344F-00D8-41C3-90D8-2265542088FDQ35236271-42D300D9-71C1-405A-AD0B-503EF3992219Q35236282-3FD102FC-45EC-4A0A-A79B-CCEB42D37F81Q35236607-7C120A5C-83FF-4880-AC8B-0B7EF8D4A135Q36054203-5684C8B1-F976-43ED-832D-99D6B38388CEQ36359827-FD53F4F1-8CC1-467E-BE0E-17FC84D8728EQ36401916-26B0B153-F9DF-4475-9A4B-3F8FBF202157Q36666237-AE2CBB67-C828-403A-BFBC-049B99455E28Q36981190-BE959B6B-62FD-4F6A-94F6-FDC4153A9FC6Q37148337-3B796E9D-5B30-45A1-A4B6-601D32864D23Q37285460-3391D116-C487-46F6-9401-B1A10E866645Q37356297-98EE384D-FAFC-4D8D-B988-372B9F95A024Q39810959-5E4F696E-D018-4B26-A3D9-AE5ECDCE56A8Q44045755-C9E67434-8DE2-4073-B575-BF947E92D4B8Q46470298-27CF552D-D545-4EA2-B42D-1A14831105B8Q48314987-212692A3-56A2-4E0E-B237-80307E6C6CC3Q48557473-892F3505-1563-4210-87A7-EF9E1132A461
P2860
Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Hippocampal N-acetyl aspartate ...... ate neurobiological phenotype.
@en
Hippocampal N-acetyl aspartate ...... ate neurobiological phenotype.
@nl
type
label
Hippocampal N-acetyl aspartate ...... ate neurobiological phenotype.
@en
Hippocampal N-acetyl aspartate ...... ate neurobiological phenotype.
@nl
prefLabel
Hippocampal N-acetyl aspartate ...... ate neurobiological phenotype.
@en
Hippocampal N-acetyl aspartate ...... ate neurobiological phenotype.
@nl
P2093
P1476
Hippocampal N-acetyl aspartate ...... ate neurobiological phenotype.
@en
P2093
P304
P356
10.1016/S0006-3223(98)00264-9
P407
P577
1998-11-01T00:00:00Z